Private Equity Screener Refer

MARKET INSIGHTS

EventsNEWPrivate market milestones
NewsPrecize daily pulse
BlogsIn-depth articles and opinions

GUIDES

Unlisted SharesStep-by-step · KYC
BuyingStep-by-step · KYC
SellingExit in 24 - 48 hours
Pre-IPOReturns · risks · case studies
Tax GuideBudget 2026 changes

PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits; Rahul Guha takes over

Home
Unlisted share news
PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits…

PharmEasy CEO Siddharth Shah steps down amid string of co-founder exits; Rahul Guha takes over

7 Aug 2025

Add as preferred source

Key Takeaways

Leadership shift and financial tightening signal operational refocus, but investors should watch for clarity on the revived IPO timeline.

Leadership shift and financial tightening signal operational refocus, but investors should watch for clarity on the revived IPO timeline.

API Holdings (Pharmeasy)

-1.80%

Expert Analysis

API Holdings Appoints Rahul Guha as CEO Amid Leadership Restructuring and Financial Refocus.

Expert Analysis :

Leadership Transition: API Holdings has appointed Rahul Guha as Managing Director and CEO, effective August 27, 2025, replacing co-founder Siddharth Shah, who becomes Vice Chairman.
Management Background: Guha, currently CEO of Thyrocare and President of Operations at API, will continue both roles while leading API.
Financial Snapshot: In FY24, revenue declined 15 percent YoY to $660 million while net losses reduced to $300 million due to cost controls.
Valuation Decline: PharmEasy’s valuation fell from $5.6 billion to $700 million during a $216 million fundraise in April 2024.
Strategic Outlook: Guha's appointment signals a focus on operational execution and profitability. An IPO is still planned, with no set timeline.

Publisher:Money Control